Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-16

Clinical Trial Update: Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A multi-center Phase 2 randomized trial is investigating irreversible electroporation (IRE) for ablation of localized prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Clinical Research Office of the Endourological Society | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN